nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—ANKK1—schizophrenia	0.631	1	CbGaD
Ruxolitinib—HIPK2—forebrain—schizophrenia	0.000803	0.0054	CbGeAlD
Ruxolitinib—JAK1—telencephalon—schizophrenia	0.000791	0.00532	CbGeAlD
Ruxolitinib—DCLK1—telencephalon—schizophrenia	0.000791	0.00532	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—schizophrenia	0.000783	0.00526	CbGeAlD
Ruxolitinib—RPS6KA6—endocrine gland—schizophrenia	0.000779	0.00524	CbGeAlD
Ruxolitinib—PLK1—endocrine gland—schizophrenia	0.000779	0.00524	CbGeAlD
Ruxolitinib—GRK1—nervous system—schizophrenia	0.000775	0.00522	CbGeAlD
Ruxolitinib—PRKCE—nervous system—schizophrenia	0.000759	0.0051	CbGeAlD
Ruxolitinib—DAPK2—telencephalon—schizophrenia	0.000754	0.00507	CbGeAlD
Ruxolitinib—PLK3—blood—schizophrenia	0.00075	0.00504	CbGeAlD
Ruxolitinib—GRK1—central nervous system—schizophrenia	0.000747	0.00502	CbGeAlD
Ruxolitinib—ROCK1—forebrain—schizophrenia	0.000741	0.00498	CbGeAlD
Ruxolitinib—HIPK2—telencephalon—schizophrenia	0.000738	0.00497	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—schizophrenia	0.000731	0.00491	CbGeAlD
Ruxolitinib—PLK1—nervous system—schizophrenia	0.000729	0.0049	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—schizophrenia	0.000729	0.0049	CbGeAlD
Ruxolitinib—MAST1—nervous system—schizophrenia	0.000729	0.0049	CbGeAlD
Ruxolitinib—DYRK1A—forebrain—schizophrenia	0.000722	0.00486	CbGeAlD
Ruxolitinib—BMPR2—forebrain—schizophrenia	0.000719	0.00484	CbGeAlD
Ruxolitinib—PRKCE—cerebellum—schizophrenia	0.000714	0.0048	CbGeAlD
Ruxolitinib—DAPK3—telencephalon—schizophrenia	0.000709	0.00477	CbGeAlD
Ruxolitinib—PLK1—central nervous system—schizophrenia	0.000702	0.00472	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—schizophrenia	0.000702	0.00472	CbGeAlD
Ruxolitinib—MAST1—central nervous system—schizophrenia	0.000702	0.00472	CbGeAlD
Ruxolitinib—CAMK1—blood—schizophrenia	0.000701	0.00472	CbGeAlD
Ruxolitinib—DCLK3—nervous system—schizophrenia	0.000691	0.00465	CbGeAlD
Ruxolitinib—RPS6KA6—cerebellum—schizophrenia	0.000686	0.00461	CbGeAlD
Ruxolitinib—MAST1—cerebellum—schizophrenia	0.000686	0.00461	CbGeAlD
Ruxolitinib—ROCK1—telencephalon—schizophrenia	0.000681	0.00458	CbGeAlD
Ruxolitinib—MARK2—blood—schizophrenia	0.000681	0.00458	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—schizophrenia	0.000665	0.00448	CbGeAlD
Ruxolitinib—DYRK1A—telencephalon—schizophrenia	0.000664	0.00447	CbGeAlD
Ruxolitinib—BMPR2—telencephalon—schizophrenia	0.000662	0.00445	CbGeAlD
Ruxolitinib—JAK1—gonad—schizophrenia	0.00066	0.00444	CbGeAlD
Ruxolitinib—PLK4—gonad—schizophrenia	0.000656	0.00441	CbGeAlD
Ruxolitinib—PLK3—endocrine gland—schizophrenia	0.00065	0.00437	CbGeAlD
Ruxolitinib—CAMK2G—forebrain—schizophrenia	0.000644	0.00433	CbGeAlD
Ruxolitinib—BMP2K—forebrain—schizophrenia	0.000644	0.00433	CbGeAlD
Ruxolitinib—PHKG2—gonad—schizophrenia	0.00064	0.00431	CbGeAlD
Ruxolitinib—LRRK2—forebrain—schizophrenia	0.000638	0.00429	CbGeAlD
Ruxolitinib—TAOK2—blood—schizophrenia	0.00063	0.00424	CbGeAlD
Ruxolitinib—PRKG2—brain—schizophrenia	0.000621	0.00418	CbGeAlD
Ruxolitinib—HIPK2—gonad—schizophrenia	0.000616	0.00414	CbGeAlD
Ruxolitinib—PLK3—nervous system—schizophrenia	0.000609	0.00409	CbGeAlD
Ruxolitinib—CAMK1—endocrine gland—schizophrenia	0.000608	0.00409	CbGeAlD
Ruxolitinib—GRK1—brain—schizophrenia	0.000593	0.00399	CbGeAlD
Ruxolitinib—CAMK2G—telencephalon—schizophrenia	0.000592	0.00398	CbGeAlD
Ruxolitinib—MARK2—endocrine gland—schizophrenia	0.00059	0.00397	CbGeAlD
Ruxolitinib—LRRK2—telencephalon—schizophrenia	0.000587	0.00395	CbGeAlD
Ruxolitinib—CLK2—gonad—schizophrenia	0.000586	0.00394	CbGeAlD
Ruxolitinib—PLK3—central nervous system—schizophrenia	0.000586	0.00394	CbGeAlD
Ruxolitinib—PRKCE—brain—schizophrenia	0.00058	0.0039	CbGeAlD
Ruxolitinib—JAK3—blood—schizophrenia	0.000579	0.00389	CbGeAlD
Ruxolitinib—JAK1—blood—schizophrenia	0.000575	0.00387	CbGeAlD
Ruxolitinib—PLK4—blood—schizophrenia	0.000572	0.00384	CbGeAlD
Ruxolitinib—CAMK1—nervous system—schizophrenia	0.000569	0.00383	CbGeAlD
Ruxolitinib—ROCK1—gonad—schizophrenia	0.000568	0.00382	CbGeAlD
Ruxolitinib—JAK1—midbrain—schizophrenia	0.000568	0.00382	CbGeAlD
Ruxolitinib—DCLK1—midbrain—schizophrenia	0.000568	0.00382	CbGeAlD
Ruxolitinib—CAMK1D—blood—schizophrenia	0.000561	0.00378	CbGeAlD
Ruxolitinib—PLK1—brain—schizophrenia	0.000557	0.00375	CbGeAlD
Ruxolitinib—RPS6KA6—brain—schizophrenia	0.000557	0.00375	CbGeAlD
Ruxolitinib—MAST1—brain—schizophrenia	0.000557	0.00375	CbGeAlD
Ruxolitinib—DYRK1A—gonad—schizophrenia	0.000554	0.00373	CbGeAlD
Ruxolitinib—MARK2—nervous system—schizophrenia	0.000553	0.00372	CbGeAlD
Ruxolitinib—DAPK2—blood—schizophrenia	0.000549	0.00369	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—schizophrenia	0.000548	0.00369	CbGeAlD
Ruxolitinib—DAPK2—midbrain—schizophrenia	0.000542	0.00364	CbGeAlD
Ruxolitinib—STK16—blood—schizophrenia	0.00054	0.00363	CbGeAlD
Ruxolitinib—MAP3K2—telencephalon—schizophrenia	0.000538	0.00362	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—schizophrenia	0.000536	0.0036	CbGeAlD
Ruxolitinib—MAP3K7—telencephalon—schizophrenia	0.000533	0.00358	CbGeAlD
Ruxolitinib—MARK2—central nervous system—schizophrenia	0.000532	0.00358	CbGeAlD
Ruxolitinib—DCLK3—brain—schizophrenia	0.000528	0.00355	CbGeAlD
Ruxolitinib—TYK2—telencephalon—schizophrenia	0.000523	0.00352	CbGeAlD
Ruxolitinib—MARK2—cerebellum—schizophrenia	0.00052	0.0035	CbGeAlD
Ruxolitinib—JAK2—forebrain—schizophrenia	0.000517	0.00348	CbGeAlD
Ruxolitinib—IRAK1—telencephalon—schizophrenia	0.000516	0.00347	CbGeAlD
Ruxolitinib—MKNK2—telencephalon—schizophrenia	0.000516	0.00347	CbGeAlD
Ruxolitinib—DAPK3—blood—schizophrenia	0.000516	0.00347	CbGeAlD
Ruxolitinib—CLK2—blood—schizophrenia	0.000511	0.00344	CbGeAlD
Ruxolitinib—DAPK3—midbrain—schizophrenia	0.000509	0.00343	CbGeAlD
Ruxolitinib—JAK3—endocrine gland—schizophrenia	0.000502	0.00338	CbGeAlD
Ruxolitinib—DCLK1—endocrine gland—schizophrenia	0.000499	0.00336	CbGeAlD
Ruxolitinib—JAK1—endocrine gland—schizophrenia	0.000499	0.00336	CbGeAlD
Ruxolitinib—PLK4—endocrine gland—schizophrenia	0.000496	0.00333	CbGeAlD
Ruxolitinib—ROCK1—blood—schizophrenia	0.000495	0.00333	CbGeAlD
Ruxolitinib—BMP2K—gonad—schizophrenia	0.000494	0.00332	CbGeAlD
Ruxolitinib—LRRK2—gonad—schizophrenia	0.00049	0.00329	CbGeAlD
Ruxolitinib—CAMK1D—endocrine gland—schizophrenia	0.000487	0.00327	CbGeAlD
Ruxolitinib—PHKG2—endocrine gland—schizophrenia	0.000484	0.00326	CbGeAlD
Ruxolitinib—CYP3A4—urine—schizophrenia	0.000483	0.00325	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—schizophrenia	0.000481	0.00324	CbGeAlD
Ruxolitinib—JAK2—telencephalon—schizophrenia	0.000476	0.0032	CbGeAlD
Ruxolitinib—BMPR2—midbrain—schizophrenia	0.000475	0.0032	CbGeAlD
Ruxolitinib—JAK3—nervous system—schizophrenia	0.00047	0.00316	CbGeAlD
Ruxolitinib—STK16—endocrine gland—schizophrenia	0.000468	0.00315	CbGeAlD
Ruxolitinib—JAK1—nervous system—schizophrenia	0.000467	0.00314	CbGeAlD
Ruxolitinib—DCLK1—nervous system—schizophrenia	0.000467	0.00314	CbGeAlD
Ruxolitinib—HIPK2—endocrine gland—schizophrenia	0.000466	0.00313	CbGeAlD
Ruxolitinib—PLK3—brain—schizophrenia	0.000465	0.00313	CbGeAlD
Ruxolitinib—NUAK2—blood—schizophrenia	0.00046	0.00309	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—schizophrenia	0.000456	0.00307	CbGeAlD
Ruxolitinib—TAOK3—forebrain—schizophrenia	0.000455	0.00306	CbGeAlD
Ruxolitinib—PHKG2—nervous system—schizophrenia	0.000453	0.00305	CbGeAlD
Ruxolitinib—JAK3—central nervous system—schizophrenia	0.000452	0.00304	CbGeAlD
Ruxolitinib—JAK1—central nervous system—schizophrenia	0.000449	0.00302	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—schizophrenia	0.000449	0.00302	CbGeAlD
Ruxolitinib—LTK—brain—schizophrenia	0.000449	0.00302	CbGeAlD
Ruxolitinib—MAP3K2—gonad—schizophrenia	0.000449	0.00302	CbGeAlD
Ruxolitinib—DAPK3—endocrine gland—schizophrenia	0.000447	0.00301	CbGeAlD
Ruxolitinib—CLK2—endocrine gland—schizophrenia	0.000443	0.00298	CbGeAlD
Ruxolitinib—JAK3—cerebellum—schizophrenia	0.000442	0.00297	CbGeAlD
Ruxolitinib—JAK1—cerebellum—schizophrenia	0.000439	0.00296	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—schizophrenia	0.000439	0.00296	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—schizophrenia	0.000439	0.00295	CbGeAlD
Ruxolitinib—STK16—nervous system—schizophrenia	0.000438	0.00295	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—schizophrenia	0.000436	0.00293	CbGeAlD
Ruxolitinib—HIPK2—nervous system—schizophrenia	0.000436	0.00293	CbGeAlD
Ruxolitinib—CAMK1—brain—schizophrenia	0.000435	0.00293	CbGeAlD
Ruxolitinib—MKNK2—gonad—schizophrenia	0.000431	0.0029	CbGeAlD
Ruxolitinib—CAMK2G—blood—schizophrenia	0.000431	0.0029	CbGeAlD
Ruxolitinib—BMP2K—blood—schizophrenia	0.000431	0.0029	CbGeAlD
Ruxolitinib—ROCK1—endocrine gland—schizophrenia	0.00043	0.00289	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—schizophrenia	0.000429	0.00288	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—schizophrenia	0.000427	0.00287	CbGeAlD
Ruxolitinib—LRRK2—blood—schizophrenia	0.000427	0.00287	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—schizophrenia	0.000426	0.00287	CbGeAlD
Ruxolitinib—CAMK2G—midbrain—schizophrenia	0.000425	0.00286	CbGeAlD
Ruxolitinib—BMP2K—midbrain—schizophrenia	0.000425	0.00286	CbGeAlD
Ruxolitinib—MARK2—brain—schizophrenia	0.000422	0.00284	CbGeAlD
Ruxolitinib—STK16—central nervous system—schizophrenia	0.000422	0.00284	CbGeAlD
Ruxolitinib—LRRK2—midbrain—schizophrenia	0.000421	0.00283	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—schizophrenia	0.00042	0.00282	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—schizophrenia	0.000419	0.00282	CbGeAlD
Ruxolitinib—DYRK1A—endocrine gland—schizophrenia	0.000419	0.00282	CbGeAlD
Ruxolitinib—DAPK3—nervous system—schizophrenia	0.000419	0.00282	CbGeAlD
Ruxolitinib—TAOK3—telencephalon—schizophrenia	0.000418	0.00281	CbGeAlD
Ruxolitinib—BMPR2—endocrine gland—schizophrenia	0.000417	0.00281	CbGeAlD
Ruxolitinib—CLK2—nervous system—schizophrenia	0.000415	0.00279	CbGeAlD
Ruxolitinib—STK16—cerebellum—schizophrenia	0.000412	0.00277	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—schizophrenia	0.000411	0.00277	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—schizophrenia	0.00041	0.00276	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—schizophrenia	0.000403	0.00271	CbGeAlD
Ruxolitinib—ROCK1—nervous system—schizophrenia	0.000402	0.0027	CbGeAlD
Ruxolitinib—CLK2—central nervous system—schizophrenia	0.000399	0.00269	CbGeAlD
Ruxolitinib—JAK2—gonad—schizophrenia	0.000397	0.00267	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—schizophrenia	0.000394	0.00265	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—schizophrenia	0.000392	0.00264	CbGeAlD
Ruxolitinib—MAP3K2—blood—schizophrenia	0.000391	0.00263	CbGeAlD
Ruxolitinib—TAOK2—brain—schizophrenia	0.000391	0.00263	CbGeAlD
Ruxolitinib—BMPR2—nervous system—schizophrenia	0.000391	0.00263	CbGeAlD
Ruxolitinib—CLK2—cerebellum—schizophrenia	0.00039	0.00263	CbGeAlD
Ruxolitinib—MAP3K7—blood—schizophrenia	0.000387	0.0026	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—schizophrenia	0.000387	0.0026	CbGeAlD
Ruxolitinib—MAP3K3—gonad—schizophrenia	0.000383	0.00257	CbGeAlD
Ruxolitinib—MAP3K7—midbrain—schizophrenia	0.000382	0.00257	CbGeAlD
Ruxolitinib—TYK2—blood—schizophrenia	0.00038	0.00256	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—schizophrenia	0.000378	0.00254	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—schizophrenia	0.000376	0.00253	CbGeAlD
Ruxolitinib—TYK2—midbrain—schizophrenia	0.000376	0.00253	CbGeAlD
Ruxolitinib—MKNK2—blood—schizophrenia	0.000375	0.00252	CbGeAlD
Ruxolitinib—IRAK1—blood—schizophrenia	0.000375	0.00252	CbGeAlD
Ruxolitinib—BMP2K—endocrine gland—schizophrenia	0.000373	0.00251	CbGeAlD
Ruxolitinib—CAMK2G—endocrine gland—schizophrenia	0.000373	0.00251	CbGeAlD
Ruxolitinib—MKNK2—midbrain—schizophrenia	0.000371	0.00249	CbGeAlD
Ruxolitinib—IRAK1—midbrain—schizophrenia	0.000371	0.00249	CbGeAlD
Ruxolitinib—LRRK2—endocrine gland—schizophrenia	0.00037	0.00249	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—schizophrenia	0.000369	0.00248	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—schizophrenia	0.000368	0.00247	CbGeAlD
Ruxolitinib—RET—blood—schizophrenia	0.000366	0.00246	CbGeAlD
Ruxolitinib—RET—midbrain—schizophrenia	0.000361	0.00243	CbGeAlD
Ruxolitinib—JAK3—brain—schizophrenia	0.000359	0.00242	CbGeAlD
Ruxolitinib—DCLK1—brain—schizophrenia	0.000357	0.0024	CbGeAlD
Ruxolitinib—JAK1—brain—schizophrenia	0.000357	0.0024	CbGeAlD
Ruxolitinib—PLK4—brain—schizophrenia	0.000355	0.00239	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—schizophrenia	0.000351	0.00236	CbGeAlD
Ruxolitinib—BMP2K—nervous system—schizophrenia	0.000349	0.00235	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—schizophrenia	0.000349	0.00235	CbGeAlD
Ruxolitinib—CAMK1D—brain—schizophrenia	0.000348	0.00234	CbGeAlD
Ruxolitinib—LRRK2—nervous system—schizophrenia	0.000346	0.00233	CbGeAlD
Ruxolitinib—PHKG2—brain—schizophrenia	0.000346	0.00233	CbGeAlD
Ruxolitinib—JAK2—blood—schizophrenia	0.000346	0.00233	CbGeAlD
Ruxolitinib—DAPK2—brain—schizophrenia	0.00034	0.00229	CbGeAlD
Ruxolitinib—MAP3K2—endocrine gland—schizophrenia	0.000339	0.00228	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—schizophrenia	0.000336	0.00226	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—schizophrenia	0.000336	0.00226	CbGeAlD
Ruxolitinib—STK16—brain—schizophrenia	0.000335	0.00225	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—schizophrenia	0.000333	0.00224	CbGeAlD
Ruxolitinib—MAP3K3—blood—schizophrenia	0.000333	0.00224	CbGeAlD
Ruxolitinib—HIPK2—brain—schizophrenia	0.000333	0.00224	CbGeAlD
Ruxolitinib—TYK2—endocrine gland—schizophrenia	0.00033	0.00222	CbGeAlD
Ruxolitinib—MAP3K3—midbrain—schizophrenia	0.000329	0.00221	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—schizophrenia	0.000329	0.00221	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—schizophrenia	0.000329	0.00221	CbGeAlD
Ruxolitinib—MAP3K19—brain—schizophrenia	0.000326	0.0022	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—schizophrenia	0.000326	0.00219	CbGeAlD
Ruxolitinib—MKNK2—endocrine gland—schizophrenia	0.000326	0.00219	CbGeAlD
Ruxolitinib—DAPK3—brain—schizophrenia	0.00032	0.00215	CbGeAlD
Ruxolitinib—RET—endocrine gland—schizophrenia	0.000317	0.00214	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—schizophrenia	0.000317	0.00213	CbGeAlD
Ruxolitinib—CLK2—brain—schizophrenia	0.000317	0.00213	CbGeAlD
Ruxolitinib—TYK2—nervous system—schizophrenia	0.000309	0.00208	CbGeAlD
Ruxolitinib—ROCK1—brain—schizophrenia	0.000307	0.00207	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—schizophrenia	0.000306	0.00206	CbGeAlD
Ruxolitinib—MKNK2—nervous system—schizophrenia	0.000305	0.00205	CbGeAlD
Ruxolitinib—TAOK3—blood—schizophrenia	0.000304	0.00204	CbGeAlD
Ruxolitinib—TAOK3—midbrain—schizophrenia	0.0003	0.00202	CbGeAlD
Ruxolitinib—JAK2—endocrine gland—schizophrenia	0.0003	0.00202	CbGeAlD
Ruxolitinib—DYRK1A—brain—schizophrenia	0.0003	0.00202	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—schizophrenia	0.000299	0.00201	CbGeAlD
Ruxolitinib—BMPR2—brain—schizophrenia	0.000299	0.00201	CbGeAlD
Ruxolitinib—TYK2—central nervous system—schizophrenia	0.000297	0.002	CbGeAlD
Ruxolitinib—RET—nervous system—schizophrenia	0.000297	0.002	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—schizophrenia	0.000296	0.00199	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—schizophrenia	0.000293	0.00197	CbGeAlD
Ruxolitinib—TYK2—cerebellum—schizophrenia	0.000291	0.00195	CbGeAlD
Ruxolitinib—MAP3K3—endocrine gland—schizophrenia	0.000289	0.00195	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—schizophrenia	0.000287	0.00193	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—schizophrenia	0.000287	0.00193	CbGeAlD
Ruxolitinib—RET—central nervous system—schizophrenia	0.000286	0.00192	CbGeAlD
Ruxolitinib—NUAK2—brain—schizophrenia	0.000285	0.00192	CbGeAlD
Ruxolitinib—JAK2—nervous system—schizophrenia	0.000281	0.00189	CbGeAlD
Ruxolitinib—RET—cerebellum—schizophrenia	0.00028	0.00188	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—schizophrenia	0.000271	0.00182	CbGeAlD
Ruxolitinib—JAK2—central nervous system—schizophrenia	0.00027	0.00182	CbGeAlD
Ruxolitinib—BMP2K—brain—schizophrenia	0.000267	0.0018	CbGeAlD
Ruxolitinib—CAMK2G—brain—schizophrenia	0.000267	0.0018	CbGeAlD
Ruxolitinib—LRRK2—brain—schizophrenia	0.000265	0.00178	CbGeAlD
Ruxolitinib—JAK2—cerebellum—schizophrenia	0.000264	0.00178	CbGeAlD
Ruxolitinib—TAOK3—endocrine gland—schizophrenia	0.000264	0.00177	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—schizophrenia	0.000261	0.00175	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—schizophrenia	0.000255	0.00171	CbGeAlD
Ruxolitinib—CYP3A4—blood plasma—schizophrenia	0.000252	0.0017	CbGeAlD
Ruxolitinib—TAOK3—nervous system—schizophrenia	0.000247	0.00166	CbGeAlD
Ruxolitinib—MAP3K2—brain—schizophrenia	0.000243	0.00163	CbGeAlD
Ruxolitinib—MAP3K7—brain—schizophrenia	0.00024	0.00162	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—schizophrenia	0.000238	0.0016	CbGeAlD
Ruxolitinib—TYK2—brain—schizophrenia	0.000236	0.00159	CbGeAlD
Ruxolitinib—MKNK2—brain—schizophrenia	0.000233	0.00157	CbGeAlD
Ruxolitinib—IRAK1—brain—schizophrenia	0.000233	0.00157	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—schizophrenia	0.000232	0.00156	CbGeAlD
Ruxolitinib—RET—brain—schizophrenia	0.000227	0.00153	CbGeAlD
Ruxolitinib—JAK2—brain—schizophrenia	0.000215	0.00144	CbGeAlD
Ruxolitinib—MAP3K3—brain—schizophrenia	0.000207	0.00139	CbGeAlD
Ruxolitinib—TAOK3—brain—schizophrenia	0.000189	0.00127	CbGeAlD
Ruxolitinib—CYP3A4—blood—schizophrenia	9.24e-05	0.000621	CbGeAlD
Ruxolitinib—CYP3A4—endocrine gland—schizophrenia	8.01e-05	0.000539	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—schizophrenia	7.5e-05	0.000504	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—schizophrenia	7.22e-05	0.000486	CbGeAlD
Ruxolitinib—JAK3—Signaling Pathways—APOA1—schizophrenia	4.4e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL1B—schizophrenia	4.39e-06	2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—YWHAZ—schizophrenia	4.38e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR7—schizophrenia	4.34e-06	1.98e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—DRD2—schizophrenia	4.34e-06	1.98e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MTHFR—schizophrenia	4.34e-06	1.97e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CNR1—schizophrenia	4.32e-06	1.97e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—YWHAZ—schizophrenia	4.3e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGA—schizophrenia	4.3e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—HTR2A—schizophrenia	4.3e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—EP300—schizophrenia	4.29e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ERBB4—schizophrenia	4.28e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ERBB3—schizophrenia	4.28e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—EP300—schizophrenia	4.28e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—EP300—schizophrenia	4.26e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—ESR1—schizophrenia	4.25e-06	1.93e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PRL—schizophrenia	4.22e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—AKT1—schizophrenia	4.22e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR7—schizophrenia	4.21e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—DRD2—schizophrenia	4.21e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ERBB3—schizophrenia	4.21e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NPY—schizophrenia	4.19e-06	1.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOTCH4—schizophrenia	4.19e-06	1.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ATP2A2—schizophrenia	4.19e-06	1.91e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—EP300—schizophrenia	4.16e-06	1.89e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—EP300—schizophrenia	4.15e-06	1.89e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HTR2A—schizophrenia	4.12e-06	1.88e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PRL—schizophrenia	4.1e-06	1.87e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HTR2A—schizophrenia	4.05e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Wnt—AKT1—schizophrenia	4.05e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—OXT—schizophrenia	4.04e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1B—schizophrenia	4.04e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOE—schizophrenia	4.04e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—AKT1—schizophrenia	4e-06	1.82e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—APOA1—schizophrenia	3.99e-06	1.82e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PRL—schizophrenia	3.98e-06	1.81e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—AKT1—schizophrenia	3.97e-06	1.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ERBB4—schizophrenia	3.96e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NRG1—schizophrenia	3.95e-06	1.8e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—S100B—schizophrenia	3.94e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—AKT1—schizophrenia	3.94e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—schizophrenia	3.93e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MPC2—schizophrenia	3.93e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—EP300—schizophrenia	3.92e-06	1.79e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MEF2C—schizophrenia	3.92e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HTR2A—schizophrenia	3.9e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—GSK3B—schizophrenia	3.9e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—AKT1—schizophrenia	3.9e-06	1.78e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TP53—schizophrenia	3.9e-06	1.77e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—AKT1—schizophrenia	3.89e-06	1.77e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR1A—schizophrenia	3.89e-06	1.77e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FOS—schizophrenia	3.88e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—GSK3B—schizophrenia	3.85e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NPS—schizophrenia	3.83e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOE—schizophrenia	3.83e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—S100B—schizophrenia	3.82e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—YWHAZ—schizophrenia	3.79e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—GSK3B—schizophrenia	3.79e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—APOA1—schizophrenia	3.79e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—schizophrenia	3.78e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOE—schizophrenia	3.77e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ERBB4—schizophrenia	3.76e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FOS—schizophrenia	3.76e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD1—schizophrenia	3.76e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2C—schizophrenia	3.76e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APOA1—schizophrenia	3.72e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—S100B—schizophrenia	3.71e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ERBB3—schizophrenia	3.7e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—GSK3B—schizophrenia	3.67e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—EP300—schizophrenia	3.67e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TP53—schizophrenia	3.66e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—ESR1—schizophrenia	3.66e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NTRK2—schizophrenia	3.65e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ERBB4—schizophrenia	3.65e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NRG1—schizophrenia	3.65e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLCH2—schizophrenia	3.65e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FOS—schizophrenia	3.65e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD3—schizophrenia	3.64e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—EP300—schizophrenia	3.6e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—ESR1—schizophrenia	3.6e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ERBB4—schizophrenia	3.54e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PLA2G4A—schizophrenia	3.54e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD4—schizophrenia	3.53e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—AKT1—schizophrenia	3.5e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—YWHAZ—schizophrenia	3.5e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GSK3B—schizophrenia	3.5e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NRG1—schizophrenia	3.47e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MEF2C—schizophrenia	3.44e-06	1.57e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PLA2G4A—schizophrenia	3.44e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—AKT1—schizophrenia	3.44e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NDST3—schizophrenia	3.43e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ERBB3—schizophrenia	3.42e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—AKT1—schizophrenia	3.39e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—EP300—schizophrenia	3.38e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NRG1—schizophrenia	3.37e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CNR1—schizophrenia	3.37e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—AKT1—schizophrenia	3.35e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MEF2C—schizophrenia	3.34e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PLA2G4A—schizophrenia	3.33e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—YWHAZ—schizophrenia	3.33e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—GSK3B—schizophrenia	3.32e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TP53—schizophrenia	3.31e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—DRD2—schizophrenia	3.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR7—schizophrenia	3.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—AKT1—schizophrenia	3.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—schizophrenia	3.29e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NRG1—schizophrenia	3.27e-06	1.49e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—GSK3B—schizophrenia	3.26e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ERBB3—schizophrenia	3.25e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ACSL6—schizophrenia	3.25e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC27A5—schizophrenia	3.25e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—EP300—schizophrenia	3.24e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MEF2C—schizophrenia	3.24e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—YWHAZ—schizophrenia	3.23e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ERBB3—schizophrenia	3.16e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—YWHAZ—schizophrenia	3.13e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—schizophrenia	3.13e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—EP300—schizophrenia	3.12e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRL—schizophrenia	3.11e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DAO—schizophrenia	3.1e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AKT1—schizophrenia	3.09e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—AKT1—schizophrenia	3.07e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ERBB3—schizophrenia	3.06e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOE—schizophrenia	3.06e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—schizophrenia	3.04e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOA1—schizophrenia	3.02e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EP300—schizophrenia	3.01e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—schizophrenia	2.98e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PNP—schizophrenia	2.97e-06	1.35e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—schizophrenia	2.95e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—AKT1—schizophrenia	2.93e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOE—schizophrenia	2.91e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—S100B—schizophrenia	2.9e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOA1—schizophrenia	2.88e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—schizophrenia	2.87e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—GSK3B—schizophrenia	2.87e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—AKT1—schizophrenia	2.86e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FOS—schizophrenia	2.85e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOE—schizophrenia	2.83e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—AKT1—schizophrenia	2.81e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AKT1—schizophrenia	2.8e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOA1—schizophrenia	2.79e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—schizophrenia	2.79e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ESR1—schizophrenia	2.78e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ERBB4—schizophrenia	2.77e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NDUFV2—schizophrenia	2.77e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOE—schizophrenia	2.74e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOA1—schizophrenia	2.71e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—schizophrenia	2.7e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ESR1—schizophrenia	2.7e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—AKT1—schizophrenia	2.66e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GSK3B—schizophrenia	2.65e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ESR1—schizophrenia	2.62e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PLA2G4A—schizophrenia	2.6e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIP4K2A—schizophrenia	2.6e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AKT1—schizophrenia	2.59e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—AKT1—schizophrenia	2.59e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—AKT1—schizophrenia	2.59e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—schizophrenia	2.58e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—AKT1—schizophrenia	2.57e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EP300—schizophrenia	2.57e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NRG1—schizophrenia	2.56e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EP300—schizophrenia	2.54e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MEF2C—schizophrenia	2.53e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—GSK3B—schizophrenia	2.52e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—AKT1—schizophrenia	2.51e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—AKT1—schizophrenia	2.51e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EP300—schizophrenia	2.49e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AKT1—schizophrenia	2.46e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—YWHAZ—schizophrenia	2.45e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—GSK3B—schizophrenia	2.45e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AKT1—schizophrenia	2.42e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EP300—schizophrenia	2.42e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—AKT1—schizophrenia	2.41e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ERBB3—schizophrenia	2.39e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—GSK3B—schizophrenia	2.37e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—AKT1—schizophrenia	2.37e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP26B1—schizophrenia	2.35e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—schizophrenia	2.3e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EP300—schizophrenia	2.3e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AKT1—schizophrenia	2.23e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—AKT1—schizophrenia	2.22e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AKT1—schizophrenia	2.2e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EP300—schizophrenia	2.18e-06	9.94e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—AKT1—schizophrenia	2.18e-06	9.91e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—schizophrenia	2.15e-06	9.79e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EP300—schizophrenia	2.15e-06	9.77e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—schizophrenia	2.14e-06	9.75e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOA1—schizophrenia	2.12e-06	9.64e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—schizophrenia	2.11e-06	9.62e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPH1—schizophrenia	2.1e-06	9.54e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GCLM—schizophrenia	2.1e-06	9.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ESR1—schizophrenia	2.05e-06	9.31e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—AKT1—schizophrenia	2.04e-06	9.29e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PRKD1—schizophrenia	1.97e-06	8.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—AKT1—schizophrenia	1.96e-06	8.92e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EP300—schizophrenia	1.89e-06	8.6e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—AKT1—schizophrenia	1.88e-06	8.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GSK3B—schizophrenia	1.86e-06	8.45e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AKT1—schizophrenia	1.82e-06	8.27e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—schizophrenia	1.82e-06	8.26e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EP300—schizophrenia	1.74e-06	7.94e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EP300—schizophrenia	1.66e-06	7.56e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AKT1—schizophrenia	1.65e-06	7.5e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GAPDH—schizophrenia	1.64e-06	7.49e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CLOCK—schizophrenia	1.63e-06	7.42e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EP300—schizophrenia	1.61e-06	7.33e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPH2—schizophrenia	1.59e-06	7.23e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNB2—schizophrenia	1.59e-06	7.23e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DPYD—schizophrenia	1.56e-06	7.11e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EP300—schizophrenia	1.56e-06	7.11e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—schizophrenia	1.56e-06	7.11e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—AKT1—schizophrenia	1.55e-06	7.06e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—schizophrenia	1.54e-06	6.99e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AKT1—schizophrenia	1.53e-06	6.98e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—AKT1—schizophrenia	1.51e-06	6.86e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—AKT1—schizophrenia	1.46e-06	6.65e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNA1C—schizophrenia	1.45e-06	6.61e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIK3C2A—schizophrenia	1.42e-06	6.45e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—AKT1—schizophrenia	1.39e-06	6.33e-06	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AKT1—schizophrenia	1.38e-06	6.26e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AKT1—schizophrenia	1.32e-06	6e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AKT1—schizophrenia	1.3e-06	5.91e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SNAP25—schizophrenia	1.27e-06	5.78e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP2D6—schizophrenia	1.27e-06	5.78e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AKT1—schizophrenia	1.25e-06	5.69e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EP300—schizophrenia	1.22e-06	5.56e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—schizophrenia	1.19e-06	5.41e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—schizophrenia	1.15e-06	5.25e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP1A2—schizophrenia	1.15e-06	5.23e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—AKT1—schizophrenia	1.14e-06	5.2e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TH—schizophrenia	1.13e-06	5.15e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—schizophrenia	1.12e-06	5.09e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—AKT1—schizophrenia	1.05e-06	4.8e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AKT1—schizophrenia	1e-06	4.57e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AKT1—schizophrenia	9.74e-07	4.43e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—COMT—schizophrenia	9.62e-07	4.38e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTP1—schizophrenia	9.58e-07	4.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOA—schizophrenia	9.56e-07	4.35e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AKT1—schizophrenia	9.44e-07	4.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCB1—schizophrenia	9.07e-07	4.13e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLA2G4A—schizophrenia	8.8e-07	4.01e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTM1—schizophrenia	8.8e-07	4.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—schizophrenia	8.74e-07	3.98e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—schizophrenia	7.78e-07	3.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AKT1—schizophrenia	7.38e-07	3.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—schizophrenia	7.24e-07	3.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOA1—schizophrenia	7.16e-07	3.26e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EP300—schizophrenia	4.13e-07	1.88e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—AKT1—schizophrenia	2.49e-07	1.14e-06	CbGpPWpGaD
